Bohen Sean 4
4 · Olema Pharmaceuticals, Inc. · Filed Feb 5, 2024
Insider Transaction Report
Form 4
Bohen Sean
DirectorPRESIDENT AND CEO
Transactions
- Award
Stock Option (Right to Buy)
2024-02-01+621,500→ 621,500 totalExercise: $15.25Exp: 2034-01-31→ Common Stock (621,500 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on February 1, 2025 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.